Shehroz T Rana
Shehroz T Rana
Author Response: Impact of Cerebral Microbleeds on Tau-Associated Cognitive and Structural Decline [0.03%]
作者回复：脑内微出血对tau蛋白相关认知和结构衰退的影响
Young Hee Jung,Jaelim Cho,Young Noh
Young Hee Jung
Reader Response: Impact of Cerebral Microbleeds on Tau-Associated Cognitive and Structural Decline [0.03%]
读者来信：脑深部微出血对tau蛋白相关认知和结构下降的影响
Feng Ye,Hao Liu,Jianguo Xu
Feng Ye
Nongenetic Factors Associated With Onset and Severity of Hereditary Ataxia [0.03%]
与遗传性共济失调发病及严重程度相关的非遗传因素
Hannah L Casey,Maria Springall De Pablo,Theresa A Boyle et al.
Hannah L Casey et al.
Objectives: Spinocerebellar ataxias (SCAs) are rare neurodegenerative disorders that arise from genetic sequence variants causing progressive imbalance and motor incoordination. Few studies have investigated nongenetic co...
Editors' Note: Impact of Cerebral Microbleeds on Tau-Associated Cognitive and Structural Decline [0.03%]
编者按：脑微出血对tau蛋白相关认知和结构性下降的影响
Ariane Lewis,Steven L Galetta
Ariane Lewis
Associations Between Cerebral Amyloid Angiopathy, Cognitive Impairment, and Depressive Symptoms [0.03%]
脑淀粉样血管病与认知障碍和抑郁症状的关系
Nikita Nukala,Ryan T Muir,Andrew E Beaudin et al.
Nikita Nukala et al.
Background and objectives: Cerebral amyloid angiopathy (CAA) is associated with intracerebral hemorrhage, cognitive decline, and dementia. We examined (1) associations between CAA, cognitive impairment, and depressive sym...
Rate of Autoimmune Diseases in the 10 Years Preceding Myasthenia Gravis Diagnosis: A Nationwide Cohort Study in South Korea [0.03%]
韩国全国队列研究：重症肌无力诊断前10年自身免疫性疾病的发生率
Soonwook Kwon,Bong-Seong Kim,Kyungdo Han et al.
Soonwook Kwon et al.
Background and objectives: Patients with myasthenia gravis (MG) are frequently associated with other autoimmune diseases. However, the temporal relationship between autoimmune diseases and MG remains unclear. This study a...
Eligibility for Anti-Amyloid Therapies in Patients With Biomarker-Confirmed Atypical Alzheimer Disease Phenotypes [0.03%]
生物标志物确诊的非典型阿尔茨海默病表型患者使用抗淀粉样蛋白疗法的适用性
Dror Shir,Nick Corriveau-Lecavalier,David T Jones et al.
Dror Shir et al.
Background and objectives: Clinical trials of anti-amyloid therapies (AATs) for Alzheimer disease (AD) primarily enrolled patients with mildly symptomatic, amnestic predominant presentations. The applicability of eligibil...
Calin I Prodan,Andriy Yabluchanskiy
Calin I Prodan
Editors' Note: Training the Next Generation of Neurologists to Improve Brain Health [0.03%]
编者按：培养下一代神经学家以改善脑健康
Aravind Ganesh,Steven L Galetta
Aravind Ganesh